Lidocaine as an anti‐arrhythmic drug: Are there any indications left?
Abstract Lidocaine is classified as a class Ib anti‐arrhythmic that blocks voltage‐ and pH‐dependent sodium channels. It exhibits well investigated anti‐arrhythmic effects and has been the anti‐arrhythmic of choice for the treatment of ventricular arrhythmias for several decades. Lidocaine binds pri...
Saved in:
Main Authors: | Sati Güler (Author), Hilke Könemann (Author), Julian Wolfes (Author), Fatih Güner (Author), Christian Ellermann (Author), Benjamin Rath (Author), Gerrit Frommeyer (Author), Philipp Sebastian Lange (Author), Julia Köbe (Author), Florian Reinke (Author), Lars Eckardt (Author) |
---|---|
Format: | Book |
Published: |
Wiley,
2023-12-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Antiarrhythmic Effect of Ranolazine in Combination with Selective NCX-Inhibition in an Experimental Model of Atrial Fibrillation
by: Julian Wolfes, et al.
Published: (2020) -
CaMKII-Dependent Contractile Dysfunction and Pro-Arrhythmic Activity in a Mouse Model of Obstructive Sleep Apnea
by: Philipp Hegner, et al.
Published: (2023) -
Comprehensive in vitro pro‐arrhythmic assays demonstrate that omecamtiv mecarbil has low pro‐arrhythmic risk
by: Yusheng Qu, et al.
Published: (2021) -
Effects of ranolazine on the arrhythmic substrate in hypertrophic cardiomyopathy
by: James A. Coleman, et al.
Published: (2024) -
CaMKIIδ-dependent dysregulation of atrial Na+ homeostasis promotes pro-arrhythmic activity in an obstructive sleep apnea mouse model
by: Philipp Hegner, et al.
Published: (2024)